Management of higher risk myelodysplastic syndrome
Higher risk myelodysplastic syndromes (MDS) include patients in the intermediate and high
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Higher risk myelodysplastic syndromes (MDS) include patients in the intermediate and high
Objectives: This study aims to determine the epidemiological features and problems associated
associated with Coumadin therapy. To achieve this, tight quality control in primary health care systems is undeniably important. Using finger stick device measurement of the international normalized ratio…
drugs. Sickle cell anemia (SCA) is particularly difficult to manage due to the complex pathophysiology that affects multiple organ systems. In order to improve current therapies and develop new drugs ... vary widely…
World Health Organization (WHO) has developed new system based on organ system dysfunction which incorporates clinical, laboratory and management-based criteria for identifying maternal near miss. This study was…
there are systems referredas electronic patient record or automated patient record (initiated since 1980) which have been designed to create, manage and store information of the patient ... dentist startsto practice NDA…
This course focuses on a number of systemic factors that have an
biomarkers were slow to come to clinical practice we have developed a system that uses clinical measurements commonly observed in those at risk of developing HCC and show that this ... performed on electronic data from…
After your initial phase of periodontal therapy, are you sending your patients home with a manual/power toothbrush? The Center for Disease control states that 50% of those over ... culprit of most systemic diseases…
development process yielding the benefits of affordable drugs to the common man. The stringent systems that are being put in place are for the good of the industry. The black ... major cities). Frequent interaction by…
electrified cars, storing patient documentations securely and traffic management in smart cities. When only 50,000 devices in a city deliver 500 bytes of data per second, we have more ... than 2 terabyte of data per…
electrified cars, storing patient documentations securely and traffic management in smart cities. When only 50,000 devices in a city deliver 500 bytes of data per second, we have more ... than 2 terabyte of data per…
Immunotyping has in recent years proven to be vital in the correct
This study was done to assess the knowledge of patients regarding diabetes
Background & Aim: The use of premedication and sedation has been widely accepted
Why perform a complete examination? The very core of what we do
Aim: Prospective study aimed to assess early implant failure using ITI dental
Many indigenous drugs have been described to possess medicinal properties. Virtually all
Hemovigilence is a continuous process of data collection and analysis of transfusion related adverse reactions in order to investigate their causes and outcomes, and prevent their occurrence or recurrence ... errors and…
data related to post marketing drug safety are initiated like medicines and health care products regulatory agency which operates yellow card scheme for health care professionals, patients and carers ... Administration…
reasons for under reporting of Adverse Drug Reactions (ADR?s) to spontaneous reporting systems. Adverse Drug Reactions are significant cause of morbidity and mortality, and contribute to incidence of adverse…
across provincial healthcare systems is also likely necessary to support efficient and cost-effective national implementation of PPPM! In addition to the promise of improved patient care and disease prevention ... PPPM…
Introduction: Multiple system atrophy (MSA) is a rare group of neurodegenerative syndromes including olivopontocerebellar atrophy, striatonigral degeneration, and Shy-Drager syndrome. The syndrome is rare and not…
Watch? USA, to strengthen our system. The PV programme will become success provided we adhere to greater emphasis on monitoring, proactive benefit risk ratio management, enhanced the transparency and involvement…
seen seismic changes to PV requirements that focus on patient protection, proactive PV, and the need for PV quality systems. But does this mitigate the possibility for pharma company ineptitude ... company can be…
For authors and organisers
Find the right journal for your paper and submit your manuscript.